Anavex Life Sciences Corporation (NASDAQ:AVXL) shares, rose in value on Friday, July 11, with the stock price down by -0.63% to the previous day’s close as strong demand from buyers drove the stock to $11.11.
Actively observing the price movement in the last trading, the stock closed the session at $11.18, falling within a range of $10.8701 and $11.18. The value of beta (5-year monthly) was 0.67. Referring to stock’s 52-week performance, its high was $14.44, and the low was $4.60. On the whole, AVXL has fluctuated by 36.82% over the past month.
With the market capitalization of Anavex Life Sciences Corporation currently standing at about $948.48 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that AVXL’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of AVXL currently trading nearly 15.51% and 27.13% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 69.76, while the 7-day volatility ratio is showing 6.00% which for the 30-day chart, stands at 5.70%. Furthermore, Anavex Life Sciences Corporation (AVXL)’s beta value is 0.79.
A comparison of Anavex Life Sciences Corporation (AVXL) with its peers suggests the former has fared considerably weaker in the market. AVXL showed an intraday change of -0.63% in last session, and over the past year, it grew by 3.45%%.
Data on historical trading for Anavex Life Sciences Corporation (NASDAQ:AVXL) indicates that the trading volumes over the past 10 days have averaged 1.19 and over the past 3 months, they’ve averaged 873.28K. According to company’s latest data on outstanding shares, there are 85.33 million shares outstanding.
Nearly 3.35% of Anavex Life Sciences Corporation’s shares belong to company insiders and institutional investors own 36.94% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 25.21 million shares as on 2025-06-13, resulting in a short ratio of 28.32. According to the data, the short interest in Anavex Life Sciences Corporation (AVXL) stood at 3054.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 24.1 million. The stock has risen by 144.71% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AVXL stock heading into the next quarter.
